 |
市场调查报告书
商品编码
1747285
血球因子市场：依产品类型、依来源、依应用、依给药途径、依最终使用者、按地区Blood Cell Factors Market, By Product Type, By Source, By Application, By Route of Administration, By End user, By Geography |
||||||
价格
简介目录
预计 2025 年全球血球因子市场规模为 33.7 亿美元，到 2032 年将达到 43.1 亿美元，2025 年至 2032 年的复合年增长率为 3.6%。
| 报告范围 | 报告详细信息 | ||
|---|---|---|---|
| 基准年 | 2024 | 2025年的市场规模 | 33.7亿美元 |
| 效能数据 | 2020-2024 | 预测期 | 2025-2032 |
| 预测期：2025-2032年复合年增长率： | 3.60% | 2032年价值预测 | 43.1亿美元 |
全球血球因子市场已成为医疗保健产业的重要组成部分，在各种血液疾病的治疗和管理中发挥关键作用。血球因子是调节血球因子（包括红血球、白血球和血小板）生长、分化和功能所必需的蛋白质和分子。近年来，这些因子因其有助于治疗各种血液相关疾病（包括贫血、血小板减少性疾病和血小板减少症）的潜力而引起了广泛关注。血球因子市场的发展受到血液疾病盛行率不断上升、生物技术和药物研究的进步以及对有效和有针对性的治疗需求不断增长的驱动。本文旨在全面概况全球血球因子市场，强调其现状、关键驱动因素和挑战以及未来前景。
市场动态：
全球血球因子市场受到多种关键驱动因素、市场限制因素和机会的影响。其中一个关键驱动因素是全球贫血、白血病和淋巴瘤等血液疾病发生率的上升。这些疾病的日益普及使得对血球因子相关有效治疗的需求庞大。此外，日益增长的老龄化人口更容易患上血液相关疾病，这进一步推动了市场的成长。生物技术和药物研究的进步也促进了新型标靶治疗的开发，并在推动市场发展方面发挥关键作用。然而，也存在一些市场限制因素，例如高昂的研发成本、严格的监管要求以及血球因子疗法可能产生的副作用。这些挑战可能会阻碍这些疗法的广泛采用和可及性。儘管存在这些市场限制因素，但该市场仍提供了巨大的成长和创新机会。对个人化医疗的日益关注、生物相似药的市场开发以及新兴经济体医疗基础设施的不断扩大，预计将为市场相关人员开闢新的途径。此外，製药公司、研发机构和政府机构之间的合作预计将加速血球因子疗法的市场开发和商业化，预计这将推动未来的市场成长。
本研究的主要特点
- 本报告对全球血球因子市场进行了详细分析，并展示了预测期（2025-2032 年）的市场规模（以十亿美元为单位）和年复合成长率（CAGR%），以 2024 年为基准年。
- 它还强调了各个领域的潜在商机，并解释了该市场的有吸引力的投资提案矩阵。
- 它还提供了有关市场驱动因素、限制因素、机会、新产品发布和核准、市场趋势、区域前景和主要企业采用的竞争策略的重要见解。
- 全球血球因子市场的主要企业是根据公司亮点、产品系列、关键亮点、财务绩效和策略等参数进行的分析。
- 本报告的见解将使负责人和企业经营团队能够就未来的产品发布、新兴趋势、市场扩张和行销策略做出明智的决策。
- 全球血球因子市场报告迎合了该行业的各个相关人员，例如投资者、供应商、产品製造商、经销商、新进业者和金融分析师。
- 透过分析全球血球因子市场所使用的各种策略矩阵，相关人员将能够更轻鬆地做出决策。
目录
第一章 研究目的与前提
- 研究目标
- 先决条件
- 简称
第二章 市场展望
- 报告描述
- 市场定义和范围
- 执行摘要
第三章市场动态、法规与趋势分析
- 市场动态
- 影响分析
- 主要进展
- 监管情景
- 产品发布/核准
- PEST分析
- 波特分析
- 併购场景
- 产业趋势
4. 2020 年至 2032 年全球血球因子市场（依产品类型）
- 促红血球生成素刺激剂 (ESA)
- 颗粒细胞增生因子（G-CSF）
- 粒细胞-巨噬细胞集落刺激因子（GM-CSF）
- 血小板生成素受体促效剂
- 干细胞因子
- 其他血球因子（例如白细胞介素）
5. 全球血球因子市场（依来源划分），2020 年至 2032 年
- 重组（源自rDNA技术）
- 天然（血浆衍生）
6. 全球血球因子市场（依应用划分），2020-2032
- 肿瘤学
- 肾臟病学
- 血液系统疾病
- 感染疾病
- 自体免疫疾病
- 其他（例如，HIV相关贫血）
7. 全球血球激素市场（依给药途径划分），2020 年至 2032 年
- 注射
- 口服
8. 全球血球因子市场（依最终用户划分），2020 年至 2032 年
- 医院
- 门诊手术中心
- 家庭医疗保健
- 专科诊所
- 研究和学术机构
- 其他的
9. 2020 年至 2032 年按地区分類的全球血球因子市场
- 北美洲
- 美国
- 加拿大
- 拉丁美洲
- 巴西
- 阿根廷
- 墨西哥
- 其他拉丁美洲
- 欧洲
- 德国
- 英国
- 西班牙
- 法国
- 义大利
- 俄罗斯
- 其他欧洲国家
- 亚太地区
- 中国
- 印度
- 日本
- 澳洲
- 韩国
- ASEAN
- 其他亚太地区
- 中东
- 海湾合作委员会国家
- 以色列
- 其他中东地区
- 非洲
- 南非
- 北非
- 中部非洲
第十章 竞争格局
- Amgen Inc.
- Johnson & Johnson
- Roche Holding AG
- Novartis AG
- Pfizer Inc.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Gilead Sciences, Inc.
- Sanofi SA
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Celgene Corporation
- Takeda Pharmaceutical Company Limited
- Regeneron Pharmaceuticals, Inc.
第 11 章分析师建议
- 命运之轮
- 分析师观点
- Coherent Opportunity Map
第十二章参考文献与调查方法
- 参考
- 调查方法
- 关于出版商
简介目录
Product Code: CMI7942
Global Blood Cell Factors Market is estimated to be valued at USD 3.37 Bn in 2025 and is expected to reach USD 4.31 Bn by 2032, growing at a compound annual growth rate (CAGR) of 3.6% from 2025 to 2032.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2024 | Market Size in 2025: | USD 3.37 Bn |
| Historical Data for: | 2020 to 2024 | Forecast Period: | 2025 To 2032 |
| Forecast Period 2025 to 2032 CAGR: | 3.60% | 2032 Value Projection: | USD 4.31 Bn |
The global blood cell factors market has emerged as a critical component of the healthcare industry, playing a vital role in the treatment and management of various hematological disorders. Blood cell factors are essential proteins and molecules that regulate the growth, differentiation, and function of blood cells, including red blood cells, white blood cells, and platelets. These factors have gained significant attention in recent years due to their potential in treating a wide range of blood-related diseases, such as anemia, leukemia, and thrombocytopenia. The market for blood cell factors is driven by the increasing prevalence of hematological disorders, advancements in biotechnology and pharmaceutical research, and the growing demand for effective and targeted therapies. This article aims to provide a comprehensive overview of the global blood cell factors market, highlighting its current state, key drivers, challenges, and future prospects.
Market Dynamics:
The global blood cell factors market is influenced by several key drivers, restraints, and opportunities. One of the primary drivers is the rising incidence of hematological disorders worldwide, such as anemia, leukemia, and lymphoma. The increasing prevalence of these diseases has created a significant demand for effective treatments, including blood cell factors. Additionally, the growing aging population, which is more susceptible to blood-related disorders, has further fueled the market growth. Advancements in biotechnology and pharmaceutical research have also played a crucial role in driving the market, enabling the development of novel and targeted therapies. However, the market also faces certain restraints, such as the high cost of research and development, stringent regulatory requirements, and the potential side effects associated with blood cell factor therapies. These challenges can hinder the adoption and accessibility of these treatments. Despite these restraints, the market presents significant opportunities for growth and innovation. The increasing focus on personalized medicine, the development of biosimilars, and the expansion of healthcare infrastructure in emerging economies are expected to create new avenues for market players. Moreover, collaborations between pharmaceutical companies, research institutions, and government organizations are likely to accelerate the development and commercialization of blood cell factor therapies, thereby driving market growth in the coming years.
Key features of the study:
- This report provides in-depth analysis of the global blood cell factors market, and provides market size (USD Bn) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global blood cell factors market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Amgen Inc., Johnson & Johnson, Roche Holding AG, Novartis AG, Pfizer Inc., Bristol-Myers Squibb Company, Eli Lilly and Company, Gilead Sciences, Inc., Sanofi S.A., Merck & Co., Inc., Teva Pharmaceutical Industries Ltd., AbbVie Inc., Celgene Corporation, Takeda Pharmaceutical Company Limited, and Regeneron Pharmaceuticals, Inc.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global blood cell factors market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global blood cell factors market.
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2020 - 2032)
- Erythropoietin Stimulating Agents (ESAs)
- Granulocyte Colony-Stimulating Factor (G-CSF)
- Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
- Thrombopoietin Receptor Agonists
- Stem Cell Factor
- Other Blood Cell Factors (e.g. Interleukins)
- Source Insights (Revenue, USD Bn, 2020 - 2032)
- Recombinant (rDNA technology-derived)
- Natural (Plasma-derived)
- Application Insights (Revenue, USD Bn, 2020 - 2032)
- Oncology
- Nephrology
- Hematology Disorders
- Infectious Diseases
- Autoimmune Disorders
- Others (e.g., HIV-related anemia)
- Route Of Administration Insights (Revenue, USD Bn, 2020 - 2032)
- Injectable
- Oral
- End User Insights (Revenue, USD Bn, 2020 - 2032)
- Hospitals
- Ambulatory Surgical Centers
- Home Healthcare
- Specialty Clinics
- Research & Academic Institutes
- Others
- Regional Insights (Revenue, USD Bn, 2020 - 2032)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Amgen Inc.
- Johnson & Johnson
- Roche Holding AG
- Novartis AG
- Pfizer Inc.
- Bristol-Myers Squibb Company
- Eli Lilly and Company
- Gilead Sciences, Inc.
- Sanofi S.A.
- Merck & Co., Inc.
- Teva Pharmaceutical Industries Ltd.
- AbbVie Inc.
- Celgene Corporation
- Takeda Pharmaceutical Company Limited
- Regeneron Pharmaceuticals, Inc.
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Blood Cell Factors Market, By Product Type
- Global Blood Cell Factors Market, By Source
- Global Blood Cell Factors Market, By Application
- Global Blood Cell Factors Market, By Route of Administration
- Global Blood Cell Factors Market, By End user
- Global Blood Cell Factors Market, By Region
3. Market Dynamics, Regulations, And Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Blood Cell Factors Market, By Product Type, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Erythropoietin Stimulating Agents (ESAs)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Granulocyte Colony-Stimulating Factor (G-CSF)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Thrombopoietin Receptor Agonists
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Stem Cell Factor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Other Blood Cell Factors (e.g. Interleukins)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
5. Global Blood Cell Factors Market, By Source, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Recombinant (rDNA technology-derived)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Natural (Plasma-derived)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
6. Global Blood Cell Factors Market, By Application, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Oncology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Nephrology
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Hematology Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Infectious Diseases
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Autoimmune Disorders
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others (e.g., HIV-related anemia)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
7. Global Blood Cell Factors Market, By Route of Administration, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
8. Global Blood Cell Factors Market, By End User, 2020-2032, (USD Bn)
- Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Ambulatory Surgical Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Home Healthcare
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Research & Academic Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
9. Global Blood Cell Factors Market, By Region, 2020 - 2032, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2025,2028 & 2032, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2021 - 2032, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End user, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End user, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End user, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End user, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End user, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country, 2020 - 2032, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Source, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Application, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Route of Administration, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By End user, 2020 - 2032, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2020 - 2032, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
10. Competitive Landscape
- Amgen Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Johnson & Johnson
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Roche Holding AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bristol-Myers Squibb Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Eli Lilly and Company
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Gilead Sciences, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Teva Pharmaceutical Industries Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AbbVie Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Celgene Corporation
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Takeda Pharmaceutical Company Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Regeneron Pharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
11. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
12. References and Research Methodology
- References
- Research Methodology
- About us
02-2729-4219
+886-2-2729-4219
